DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q1 2025

SEC EDGAR SourceSEC Filings

Top Holdings394 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

2.7M$448.2M4.3%$64.83+152.50%
25 qtrssince 2019-Q1
Decreased
0
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

7M$221.4M2.1%$19.20+62.89%
25 qtrssince 2019-Q1
Increased
54

CRINETICS PHARMACEUTICALS IN

6.2M$209.3M2.0%$26.30+32.07%
20 qtrssince 2020-Q2
Increased
53

XENON PHARMACEUTICALS INC

4.6M$153.8M1.5%$27.52+24.47%
21 qtrssince 2020-Q1
Increased
48

SPROUTS FMRS MKT INC

971,380$148.3M1.4%$67.74+118.14%
6 qtrssince 2023-Q4
Increased
49
CYBRCYBRDelisted

CYBERARK SOFTWARE LTD

430,974$145.7M1.4%$218.08+53.96%
14 qtrssince 2021-Q4
Decreased
0

NATERA INC

944,584$133.6M1.3%$74.90+92.17%
11 qtrssince 2022-Q3
Increased
49

MERCADOLIBRE INC

62,036$121M1.2%$1,754.24+16.75%
11 qtrssince 2022-Q3
Increased
67

AXON ENTERPRISE INC

214,822$113M1.1%$219.84+139.25%
22 qtrssince 2019-Q4
Increased
51

YUM CHINA HOLDINGS INC -W/I

2.1M$110.4M1.1%$48.92+5.43%
2 qtrssince 2024-Q4
Increased
66

BELLRING BRANDS INC

1.5M$108.8M1.0%$44.89+65.24%
10 qtrssince 2022-Q4
Increased
56

CREDICORP LTD

574,504$106.9M1.0%$161.52+10.28%
5 qtrssince 2024-Q1
Increased
54

FTAI AVIATION LTD

952,968$105.8M1.0%$27.55+297.98%
9 qtrssince 2023-Q1
Decreased
0

CARPENTER TECHNOLOGY

572,946$103.8M1.0%$169.31+6.71%
3 qtrssince 2024-Q3
Increased
72

SOUTHERN COPPER CORP

1.1M$99M1.0%$82.17+5.32%
9 qtrssince 2023-Q1
Increased
43

KNIFE RIVER CORP-W/I

1.1M$97.2M0.9%$77.25+16.07%
8 qtrssince 2023-Q2
Increased
46

GLAUKOS CORP

973,625$95.8M0.9%$88.42+15.35%
8 qtrssince 2023-Q2
Increased
50

Life Time Group Holdings, Inc.

3.2M$95.6M0.9%$24.52+24.37%
3 qtrssince 2024-Q3
Increased
45
EMBJEMBJ
ADR

Embraer S.A. Sponsored ADR

2M$94.6M0.9%$25.03+84.45%
11 qtrssince 2022-Q3
Decreased
0

CURTISS-WRIGHT CORP

282,655$89.7M0.9%$238.29+32.76%
13 qtrssince 2022-Q1
Decreased
0
$10.4B
AUM
394
Positions
Q1 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
+8%Q4'23$8.3B+21%Q1'24$10B+3%Q2'24$10.3B+13%Q3'24$11.6B+4%Q4'24$12.1B-14%Q1'25$10.4B
Activity profile
$ moved · Q1'25
New21%Increased21%Decreased33%Exited25%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q10%1-4Q22%1-2Y13%2Y+55%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $10.4B across 394 positions as of Q1 2025. Top holdings: TSM (4.3%), IBN (2.1%), CRNX (2.0%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2025 Summary

Active quarter - 95 new positions, 82 exits, 125 increased. Top move: CRS (INCREASED, conviction 72). Portfolio: $10.4B across 394 positions.

Top holdings by portfolio weight

Total AUM$10B
TSM4.32%
IBN2.13%
CRNX2.02%
XENE1.48%
SFM1.43%
CYBR1.40%
NTRA1.29%
MELI1.17%
AXON1.09%
YUMC1.06%
Other1.05%

Portfolio allocation by GICS sector

Sectors11
Healthcare24.29%
Technology17.84%
Industrials15.28%
Consumer Cyclical11.88%
Financial Services11.57%
Consumer Defensive4.93%
Energy4.82%
Basic Materials4.35%
Communication Services2.49%
Real Estate1.30%
Other1.27%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used